Biohaven Pharmaceutical Holding Co. Ltd.
(NYSE : BHVN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 2.31%34.520.9%$1198.16m
JNJJohnson & Johnson 0.46%141.030.7%$1113.20m
BMYBristol-Myers Squibb Co. 0.29%59.151.0%$977.19m
MRKMerck & Co., Inc. 0.87%78.800.7%$849.39m
ABBVAbbVie, Inc. -0.25%98.891.9%$811.21m
LLYEli Lilly & Co. 0.33%163.831.1%$698.91m
AZNAstraZeneca Plc 0.92%53.811.2%$301.15m
RPRXRoyalty Pharma Plc -1.59%45.730.1%$252.67m
VXRTVaxart, Inc. -7.88%7.370.0%$224.54m
NVSNovartis AG -0.32%87.570.2%$160.39m
GSKGlaxoSmithKline Plc 0.87%41.220.2%$122.53m
RGENRepligen Corp. 1.98%126.657.2%$120.14m
NVONovo Nordisk A/S 1.05%66.370.1%$94.84m
RETAReata Pharmaceuticals, Inc. 2.56%157.853.4%$87.71m
SNYSanofi 0.68%51.620.2%$80.12m

Company Profile

Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.